EP1487783A4 - Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes - Google Patents

Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Info

Publication number
EP1487783A4
EP1487783A4 EP03710820A EP03710820A EP1487783A4 EP 1487783 A4 EP1487783 A4 EP 1487783A4 EP 03710820 A EP03710820 A EP 03710820A EP 03710820 A EP03710820 A EP 03710820A EP 1487783 A4 EP1487783 A4 EP 1487783A4
Authority
EP
European Patent Office
Prior art keywords
methods
androgen receptor
receptor modulators
selective androgen
irreversible selective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03710820A
Other languages
German (de)
English (en)
Other versions
EP1487783A2 (fr
Inventor
James Dalton
Duane D Miller
Leonid I Kirkovsky
Dong Jin Hwang
Mitchell S Steiner
Karen A Veverka
Arnab Mukherjee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tennessee Research Foundation
Original Assignee
University of Tennessee Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tennessee Research Foundation filed Critical University of Tennessee Research Foundation
Publication of EP1487783A2 publication Critical patent/EP1487783A2/fr
Publication of EP1487783A4 publication Critical patent/EP1487783A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C261/00—Derivatives of cyanic acid
    • C07C261/02—Cyanates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C265/00—Derivatives of isocyanic acid
    • C07C265/12—Derivatives of isocyanic acid having isocyanate groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/02—Thiocyanates
    • C07C331/10—Thiocyanates having sulfur atoms of thiocyanate groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
    • C07C331/16—Isothiocyanates
    • C07C331/28—Isothiocyanates having isothiocyanate groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP03710820A 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes Withdrawn EP1487783A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8467902A 2002-02-28 2002-02-28
US453704P 2002-02-28
US42024802P 2002-10-23 2002-10-23
US420248P 2002-10-23
PCT/US2003/003121 WO2003074473A2 (fr) 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Publications (2)

Publication Number Publication Date
EP1487783A2 EP1487783A2 (fr) 2004-12-22
EP1487783A4 true EP1487783A4 (fr) 2006-09-27

Family

ID=27791168

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03710820A Withdrawn EP1487783A4 (fr) 2002-02-28 2003-02-24 Modulateurs irreversibles selectifs de recepteur d'androgene et procede d'utilisation associes

Country Status (12)

Country Link
EP (1) EP1487783A4 (fr)
JP (1) JP2005519111A (fr)
KR (1) KR20040104463A (fr)
CN (1) CN1646479A (fr)
AU (1) AU2003214971A1 (fr)
CA (1) CA2476651A1 (fr)
EA (1) EA200401121A1 (fr)
HR (1) HRP20040851A2 (fr)
IL (1) IL163742A0 (fr)
MX (1) MXPA04008412A (fr)
TW (1) TW200304806A (fr)
WO (1) WO2003074473A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
WO2004035738A2 (fr) 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Modulateurs selectifs du recepteur des androgenes a liaison methylene et procedes d'utilisation associes
WO2004035737A2 (fr) * 2002-10-15 2004-04-29 University Of Tennessee Research Foundation Modulateurs heterocycliques selectifs du recepteur des androgenes et procedes d'utilisation associes
WO2004062612A2 (fr) * 2003-01-13 2004-07-29 Gtx Inc. Synthese a grande echelle de modulateurs selectifs de recepteur d'androgene
JP2006516286A (ja) * 2003-01-22 2006-06-29 ジーティーエックス・インコーポレイテッド Ｓａｒｍによる女性のアンドロゲン減少に関連する病気の治療
JP2007513998A (ja) * 2003-12-16 2007-05-31 ジーティーエックス・インコーポレイテッド 選択的アンドロゲン受容体調節剤のプロドラッグ及びその使用方法
BRPI0507670A (pt) 2004-02-13 2007-07-17 Warner Lambert Co moduladores do receptor de androgênio
CA2563291A1 (fr) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Derives de 4-cyanophenoxy-alkylcarboxyle comme modulateurs androgenes
WO2005102990A1 (fr) * 2004-04-22 2005-11-03 Warner-Lambert Company Llc Modulateurs des androgenes
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP1781598A1 (fr) 2004-07-08 2007-05-09 Warner-Lambert Company LLC Modulateurs d'androgenes
JP2008509986A (ja) * 2004-08-18 2008-04-03 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
CA2934772C (fr) * 2013-12-23 2021-04-27 Bcn Peptides, S.A. Analogues de bicalutamide ou (s)-bicalutamide en tant que composes activant l'exocytose destines au traitement de trouble de surcharge lysosomale ou de glycogenose
US10654809B2 (en) 2016-06-10 2020-05-19 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10093613B2 (en) 2015-04-21 2018-10-09 Gtx, Inc. Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10314797B2 (en) * 2016-06-10 2019-06-11 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10806720B2 (en) 2015-04-21 2020-10-20 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US10865184B2 (en) 2015-04-21 2020-12-15 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
US11230523B2 (en) 2016-06-10 2022-01-25 University Of Tennessee Research Foundation Selective androgen receptor degrader (SARD) ligands and methods of use thereof
CN113137836B (zh) * 2021-04-23 2023-04-07 柳州东风容泰化工股份有限公司 一种制备邻氯苯腈的干燥方法及系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053826A1 (fr) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Composes agonistes non steroidiens et leur utilisation dans le cadre de therapies a base d'hormones males
WO2002016310A1 (fr) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Modulateurs selectifs du recepteur androgenique et procedes d'utilisation de ces derniers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998053826A1 (fr) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Composes agonistes non steroidiens et leur utilisation dans le cadre de therapies a base d'hormones males
WO2002016310A1 (fr) * 2000-08-24 2002-02-28 The University Of Tennessee Research Corporation Modulateurs selectifs du recepteur androgenique et procedes d'utilisation de ces derniers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DALTON J T ET AL: "Discovery of nonsteroidal androgens", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 244, no. 1, 1998, pages 1 - 4, XP002385138, ISSN: 0006-291X *
KIRKOVSKY L. ET AL: "Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 43, no. 4, 24 February 2000 (2000-02-24), pages 581 - 590, XP002207426, ISSN: 0022-2623 *

Also Published As

Publication number Publication date
HRP20040851A2 (en) 2005-02-28
AU2003214971A1 (en) 2003-09-16
JP2005519111A (ja) 2005-06-30
TW200304806A (en) 2003-10-16
EP1487783A2 (fr) 2004-12-22
WO2003074473A2 (fr) 2003-09-12
EA200401121A1 (ru) 2005-10-27
CA2476651A1 (fr) 2003-09-12
MXPA04008412A (es) 2005-05-17
IL163742A0 (en) 2005-12-18
CN1646479A (zh) 2005-07-27
WO2003074473A3 (fr) 2003-12-18
KR20040104463A (ko) 2004-12-10

Similar Documents

Publication Publication Date Title
IL165792A0 (en) N-bridged selective androgen receptor modulators and methods of use thereof
EP1562906A4 (fr) Modulateurs heterocycliques selectifs du recepteur des androgenes et procedes d'utilisation associes
EP1562594A4 (fr) Modulateurs selectifs du recepteur des androgenes a liaison methylene et procedes d'utilisation associes
IL163742A0 (en) Irreversible selective androgen receptor modulators and methods of use thereof
EP1420796A4 (fr) Modulateurs du recepteur des androgenes et leurs procedes d'utilisation
IL154425A0 (en) Selective androgen receptor modulators and methods of use thereof
IL178717A0 (en) Metabolites of selective androgen receptor modulators and methods of use thereof
AU2003251970A8 (en) Modulators of the glucocorticoid receptor and method
IL163744A (en) Multi-substituted selective androgen receptor modulators and uses thereof
IL172042A0 (en) Prodrugs of selective androgen receptor and methods of use thereof
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
EP1718626A4 (fr) Modulateurs sulfonylpyrrolodines de la fonction du recepteur des androgenes et procede
AU2003288902A8 (en) Microcapsules and methods of use
EP1691729A4 (fr) Dispositif d'encapsulation et procedes d'utilisation
EP1521747A4 (fr) Modulateurs de kinase de type recepteur et procedes d'utilisation
AU2003294264A8 (en) Non-steroidal farnesoid x receptor modulators and methods for the use thereof
TWI340738B (en) Modulators of the glucocorticoid receptor
EP1663204A4 (fr) Modulateurs c-kit et leurs procedes d'utilisation
GB2395196B (en) Microfluidic device and methods for construction and application
AU2003290869A8 (en) Embolization device and a method of using the same
HK1079789A1 (zh) 血管靜態毒性試劑及其使用方法
EP1474445A4 (fr) Glyco-isoformes d'adiponectine, et utilisations correspondantes
EP1610774A4 (fr) Modulateurs de tie-2 et procedes d'utilisation
EP1611123A4 (fr) Modulateurs de tie-2 et procedes d'utilisation
EP1622567A4 (fr) Modulateurs du recepteur d'androgenes et leur methode d'utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040928

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MUKHERJEE, ARNAB

Inventor name: VEVERKA, KAREN, A.

Inventor name: STEINER, MITCHELL, S.

Inventor name: HWANG, DONG JIN

Inventor name: KIRKOVSKY, LEONID, I.

Inventor name: MILLER, DUANE, D.

Inventor name: DALTON, JAMES

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1068130

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20060824

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060901

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1068130

Country of ref document: HK